NCT01800526View on ClinicalTrials.gov

A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

January 24, 2020

Study Completion Date

June 30, 2020

Conditions
Sickle Cell DiseaseSickle Cell Anemia
Interventions
DRUG

N-Acetylcysteine

Oral and Intravenous administration of NAC

Trial Locations (1)

98106

University of Washington, Seattle

All Listed Sponsors
collaborator

University of Washington

OTHER

lead

Bloodworks

OTHER

NCT01800526 - A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease | Biotech Hunter | Biotech Hunter